Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v7-EN
Language French English
Date Updated 2022-09-06 2022-09-06
Drug Identification Number 02405776 02405776
Brand name JAMP NEVIRAPINE JAMP NEVIRAPINE
Common or Proper name Nevirapine Tablets Nevirapine Tablets
Company Name JAMP PHARMA CORPORATION JAMP PHARMA CORPORATION
Ingredients NEVIRAPINE NEVIRAPINE
Strength(s) 200MG 200MG
Dosage form(s) TABLET TABLET TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60 60
ATC code J05AG J05AG
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-05-31 2022-05-31
Estimated end date 2022-11-30 2022-11-30
Actual end date 2022-09-02 2022-09-02
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments